FR1710M - Nouveaux composés de la série de l'hydantoine pour le traitement des infections staphylococciques et colibacillosiques. - Google Patents

Nouveaux composés de la série de l'hydantoine pour le traitement des infections staphylococciques et colibacillosiques.

Info

Publication number
FR1710M
FR1710M FR882734A FR882734A FR1710M FR 1710 M FR1710 M FR 1710M FR 882734 A FR882734 A FR 882734A FR 882734 A FR882734 A FR 882734A FR 1710 M FR1710 M FR 1710M
Authority
FR
France
Prior art keywords
colibacillus
staphylococcal
infections
treatment
new compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR882734A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Application granted granted Critical
Publication of FR1710M publication Critical patent/FR1710M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electrotherapy Devices (AREA)
FR882734A 1960-12-27 1961-12-21 Nouveaux composés de la série de l'hydantoine pour le traitement des infections staphylococciques et colibacillosiques. Active FR1710M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78330A US3075973A (en) 1960-12-27 1960-12-27 3-aminoalkylated-1-(5-nitrofurfurylideneamino) hydantoins
US78331A US3075974A (en) 1960-12-27 1960-12-27 3-(2-(4-morpholino) ethyl)-1-(5-nitrofurfurylidenamino) hydantoin and acid addition salts thereof

Publications (1)

Publication Number Publication Date
FR1710M true FR1710M (fr) 1963-02-25

Family

ID=26760408

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1310190D Expired FR1310190A (fr) 1960-12-27
FR882734A Active FR1710M (fr) 1960-12-27 1961-12-21 Nouveaux composés de la série de l'hydantoine pour le traitement des infections staphylococciques et colibacillosiques.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1310190D Expired FR1310190A (fr) 1960-12-27

Country Status (8)

Country Link
US (2) US3075973A (fr)
BR (2) BR6135265D0 (fr)
CH (1) CH406232A (fr)
DE (1) DE1164416B (fr)
FR (2) FR1710M (fr)
GB (3) GB611944A (fr)
NL (3) NL272960A (fr)
SE (2) SE300109B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2669735A (en) * 1950-04-14 1954-02-23 United Shoe Machinery Corp Apparatus for attaching soles to shoes
DE976688C (de) * 1952-04-11 1964-04-02 Deutsche Edelstahlwerke Ag Induktionsheizgeraet
NL286389A (fr) * 1961-12-06
BE630615A (fr) * 1962-04-05
US3386995A (en) * 1964-06-18 1968-06-04 Norwich Pharma Co 1-substituted-3-(5-nitrofurfurylidene-amino)-2-imidazolidinones
US3367932A (en) * 1965-03-10 1968-02-06 Norwich Pharma Co 3-substituted-1-(5-nitrofurfurylideneamino)-2-imidazolidinones
US3882234A (en) * 1973-04-16 1975-05-06 Miles Lab Method of treating arrhythmias with n-(2-diethylamino)ethyl-{60 -(5,5-diphenylhydantoin-3-yl)acetamide
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
CZ282368B6 (cs) * 1991-08-14 1997-07-16 Procter And Gamble Pharmaceuticals 4-Oxocyklické močoviny a faramceutický prostředek je obsahující
SE9403698D0 (sv) * 1994-10-28 1994-10-28 Astra Ab Reactor system cleaning
US6420568B1 (en) * 1998-04-29 2002-07-16 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE515245A (fr) * 1950-05-29
US2802002A (en) * 1956-07-18 1957-08-06 Norwich Pharma Co Series of new nu-(5-nitro-2-furyl) alkylidene-3-amino-5-tertiaryamino-methyl-2-oxazolidones and the preparation thereof
BE567802A (fr) * 1958-01-23
US2990402A (en) * 1958-10-07 1961-06-27 Smith Kline French Lab Preparation of 1-aminohydantoin derivatives
NL253959A (fr) * 1959-11-27

Also Published As

Publication number Publication date
US3075974A (en) 1963-01-29
NL272959A (fr)
CH406232A (de) 1966-01-31
SE300109B (fr) 1968-04-08
GB997633A (en) 1965-07-07
GB1002645A (en) 1965-08-25
DE1164416B (de) 1964-03-05
BR6135264D0 (pt) 1973-05-15
US3075973A (en) 1963-01-29
GB611944A (en) 1948-11-05
FR1310190A (fr) 1963-03-06
NL272950A (fr)
BR6135265D0 (pt) 1973-08-07
SE300110B (fr) 1968-04-08
NL272960A (fr)

Similar Documents

Publication Publication Date Title
FR1253553A (fr) Traitement de polymères d'oxyméthylène pour en faciliter le moulage ultérieur
BE612123A (fr) Bains pour la production d'enduits métalliques.
FR1710M (fr) Nouveaux composés de la série de l'hydantoine pour le traitement des infections staphylococciques et colibacillosiques.
FR1593M (fr) Compositions pour le traitement de l'acne.
FR1320229A (fr) Production de copolymères greffés de l'acrylonitrile
FR2583M (fr) Nouveaux 2-[2-(5-nitrofuryl)-vinyl]-azoles pour le traitement des infections.
FR1009M (fr) Médicament pour le traitement de l'angine de poitrine.
FR1709M (fr) Nouveaux composés de la série de l'hydantoine pour le traitement des staphylococcies et des salmonelloses.
FR1706M (fr) Nouveaux composés antistaphylococciques de la série de l'hydantoine.
FR126M (fr) Nouveau médicament notamment pour le traitement de l'hyperlipémie post-prandiale ou chronique.
BE602260A (fr) Procédé de production d'acrylates et de méthacrylates.
BE605476A (fr) Composition vétérinaire pour le traitement de l'entérohépatite chez le dindon
OA01647A (fr) Procédé de traitement des feuilles d'agave.
BE612470A (fr) Procédé de raffinage de l'amyloglucosidase
FR94968E (fr) Procédé pour l'amélioration des possibilitiés de traitement des fines.
FR1920M (fr) Nouveau composé de la série de l'hydantoine utilisable notamment pour le traitement des salmonelloses.
FR3419M (fr) Nouveaux médicaments notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d'anxiété.
BE606544A (fr) Procédé pour le traitement de l'amiante
FR1596M (fr) Médicament pour le traitement de l'alcoolisme.
FR1299760A (fr) Procédé de raffinage de l'amyloglucosidase
FR1231M (fr) Traitement homéoflore de la sinusite et des infections dentaires.
FR1310580A (fr) Nouveaux agents de traitement, notamment pour le cuir, leur fabrication et leurs applications
FR2225M (fr) Nouvelle hydantoine de la série du nitrofurfural a propriétés antibactériennes, utilisable notamment pour le traitement des infections des voies urinaires.
FR1349978A (fr) Procédé de traitement des feuilles d'agave